Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Research
  • Published:

Oral terbutaline in the management of pharmacologically induced prolonged erection

International Journal of Impotence Research volume 16, pages 424–426 (2004)Cite this article

Abstract

Prolonged erection and priapism are common complications following intracavernosal injection of vasoactive agents in the management of erectile dysfunction. It is usually treated by intracorporeal drainage and irrigation with sympathomimetic agents. There is no established oral therapy . To study the effect of oral terbutaline on prolonged erection following intracavernosal injection of vasoactive agent, a controlled randomized study was done in 68 patients. Detumescence was achieved in 42 and 15% of the cases with oral terbutaline and placebo, respectively. Results of this study suggest that an initial trial with oral terbutaline for pharmacologically induced prolonged erection may be successful.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Lue TF, Tanagho EA . Physiology of erection and pharmacologic management of impotence. J Urol 1987; 137: 829–836.

    Article  CAS  Google Scholar 

  2. Lomas GM, Jarow JP . Risk factors for papaverine induced priapism. J Urol 1992; 147: 1280–1281.

    Article  CAS  Google Scholar 

  3. Brindley GS . New treatments for priapism (Letter). Lancet 1984; 2: 220–221.

    Article  CAS  Google Scholar 

  4. Zorgniotti AW, Lizza EF . Diagnosis and Management of Impotence. BC Decker: Philadelphia, 1991, 100pp.

    Google Scholar 

  5. Lowe FC, Jarow JP . Placebo-controlled study of oral terbutaline and pseudoephedrine in management of prostaglandin E1 induced prolonged erections. Urology 1993; 42: 51–53.

    Article  CAS  Google Scholar 

  6. Diederichs W, Stief CG, Lue TF, Tanagho EA . Sympathetic inhibition of papaverine induced erection. J Urol 1991; 146: 195–198.

    Article  CAS  Google Scholar 

  7. Shantha TR . management of penile erection by using terbutaline. Anesthesiology 1989; 70: 707–709.

    Article  CAS  Google Scholar 

  8. Shantha TR, Finnerty DP, Rodriguez AP . Treatment of persistent penile erection and priapism using terbutaline. J Urol 1989; 146: 1427–1429.

    Article  Google Scholar 

  9. Goldstein AM et al. New observations on microarchietecture of corpora cavernosa in man and possible relationship to mechanism of erection. Urology 1982; 20: 259.

    Article  CAS  Google Scholar 

  10. Wheeler AS, Patel KF, Spain J . Pulmunory oedema during beta-2 tocolytic therapy. Letter to the editor. Anesth Analg 1981; 60: 695.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Urology, SMS Medical College & Hospital, Jaipur, India

    S Priyadarshi

Authors
  1. S Priyadarshi
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to S Priyadarshi.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Priyadarshi, S. Oral terbutaline in the management of pharmacologically induced prolonged erection. Int J Impot Res 16, 424–426 (2004). https://doi.org/10.1038/sj.ijir.3901180

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.ijir.3901180

Keywords

This article is cited by

Search

Advanced search

Quick links